An optimistic outlook ‘means you live longer’

Optimists are more likely to live longer than those with a negative life view a US study has found.

Share Button

Elusive key to stopping neglected tropical diseases

Researchers at the University of Alberta have found an important protein in the cells of a deadly infectious parasite, opening the door to less harmful treatment for millions of people suffering from diseases like sleeping sickness in Africa and Chagas disease in South America.

The parasite, trypanosome, is transmitted through insect bites. In a study published in Life Science Alliance, U of A cell biologist and Canada Research Chair in Cell Biology Rick Rachubinski, and research associates Hiren Banerjee and Barbara Knobloch, found that a protein called PEX3, long believed not to exist in the parasite, was in fact present and essential for their viability.

PEX3 is a critical component of the cell biology of many living things, including humans, plants and trypanosomes. It helps make and regulate parts of the cells called peroxisomes, which help break down fatty acids and amino acids in the body to create energy.

In a trypanosome, there are specialized peroxisomes that are vital for regulating the process of turning glucose in a host’s blood into energy. Disrupting the PEX3 required for making them could be an effective way to target and kill the parasite without harming the host, according to the researchers.

“Finding PEX3 in trypanosomes has been very difficult. People have been looking for years and just could not find it,” said Rachubinski, who is also a member of the U of A’s Women and Children’s Health Research Institute. “Some people said it didn’t exist, that it was a different mechanism, but we believed that the simplest answer was that we just hadn’t found it yet.”

Finding PEX3 in trypanosomes eluded Rachubinski and his team for years until, by chance, they attended a lecture given by a researcher from Cambridge University.

In the lecture, the presenter mentioned using HHpred, a computer program offered by the Max Planck Institute for Developmental Biology in Germany, to search for proteins based on how they are predicted to fold, or turn into functional proteins, rather than the traditional way of searching by amino acid chains. Inspired, Rachubinski rushed back to his lab and used the program to compare human PEX3 against trypanosomal proteins. To his surprise, the program found a previously uncharacterized trypanosomal protein that was 95 per cent similar in its folded structure to human PEX3.

“It really was a ‘Eureka!’ moment. After years of searching, we throw this into the computer and 10 minutes later we have the answer,” he said. “It was really kind of elegant.”

Banerjee, who is the first author on the study, agreed.

“It was a great moment for our lab, especially when you have all these other papers saying PEX3 is not there,” he said.

Rachubiniski and his team are now in the process of identifying a drug treatment that targets and disrupts enough of the trypanosome’s PEX3 interactions with partner proteins to prevent the parasites from creating enough energy to survive in the body.

While current treatments for trypanosomal diseases can be highly toxic to hosts, the team’s hope is that this new approach will result in drugs that are not only safe for the hosts, but also cheap to produce and distribute.

For Rachubinski, the search for cures for neglected tropical diseases like sleeping sickness (also called human African trypanosomiasis) has been a lifelong endeavour. As an undergraduate, he was inspired by Paul de Kruif’s 1926 book Microbe Hunters, a collection of biographies and true-life stories of the scientists and researchers who first began the fight against bacteria.

“This one, to me, has been really rewarding because it’s been a constant theme throughout my career,” Rachubinski said. “This is a worldwide problem, and I’ve always believed that affluent nations like ours should help emerging nations that don’t have the resources to deal with burdens like neglected tropical diseases.

“Knowing this discovery could help millions of people is very satisfying to me.”

Rachubinski’s research was made possible in part through funding from the Canadian Institutes of Health Research.

Share Button

Wild ground-nesting bees might be exposed to lethal levels of neonics in soil

In a first-ever study investigating the risk of neonicotinoid insecticides to ground-nesting bees, University of Guelph researchers have discovered at least one species is being exposed to lethal levels of the chemicals in the soil.

Examining the presence of these commonly used pesticides in soil is important given the majority of bee species in Canada make their nests in the ground.

This study focused on hoary squash bees, which feed almost exclusively on the nectar and pollen of squash, pumpkin and gourd flowers.

Researchers found that the likelihood that squash bees are being chronically exposed to lethal doses of a key neonicotinoid, clothianidin, in soil was 36 per cent or higher in squash fields.

That means 36 per cent of the population is probably encountering lethal doses, which is well above the acceptable threshold of 5 per cent, in which 95 per cent of the bees would survive exposure.

“These findings are applicable to many other wild bee species in Canada that nest on or near farms,” said U of G School of Environmental Sciences professor, Nigel Raine, who holds the Rebanks Family Chair in Pollinator Conservation and worked on the study with PhD student and lead author Susan Chan.

“We don’t yet know what effect these pesticides are having on squash bee numbers because wild bees are not yet tracked the same way that honeybee populations are monitored. But we do know that many other wild bee species nest and forage in crop fields, which is why these findings are so concerning.”

Published in Scientific Reports, the study began with Chan collecting soil samples from 18 commercial squash fields in Ontario. Pesticide residue information from these samples and a second government dataset from field crops was used by Chan and colleagues Prof. Ryan Prosser, School of Environmental Sciences, and Dr. Jose Rodríguez-Gil to assess the risk to ground-nesting squash bees.

The research comes as Health Canada places new limits on the use of three key neonicotinoids, including clothianidin, while it decides whether to impose a full phase-out of these pesticides. Neonics have been linked to concerns about honeybee colony health, with research showing these bees can ingest dangerous amounts through nectar or pollen.

“Current risk assessments for insecticide impacts on pollinators revolve around honeybees, a species that rarely comes into contact with soil,” said Raine. “However, the majority of bee species live most of their life in soil, so risks of pesticide exposure from soil should be a major factor in these important regulatory decisions.”

“Until now, no one has examined the risk to bees from neonics in soil despite the fact these pesticides are applied directly to seeds planted into the ground, or sprayed directly onto soil at planting, and can persist for months after application,” said Chan.

“Only about 20 per cent of the neonicotinoid insecticide applied to coated seeds is actually taken up into the crop plant; the rest stays in the soil and can remain there into subsequent seasons.”

Squash bees are at particular risk because they prefer the already-tilled soil of agricultural fields for their elaborate underground homes. And as they build their nests, they move about 300 times their own body weight worth of soil.

Since the bees don’t eat soil, it’s difficult to know exactly how much pesticide residue enters the bees. But the researchers calculated that even if they are conservative and assume only 25 per cent of the clothianidin enters the bee, the risk of lethal exposure in pumpkin or squash crops is 11 per cent — still above the widely accepted threshold of 5 per cent.

The team also examined the exposure risk in field crops, since many ground-nesting bee species live near corn and soybean fields, which use neonics as well. They found that 58 per cent of ground-nesting bees would be exposed to a lethal dose of clothianidin while building their nests even if only 25 per cent of the clothianidin in the soil enters the bee.

“Pumpkin and squash farmers face a dilemma in that they want to protect pollinators, such as the squash bee, because they are vital to crop production, but at the same time need to protect their crops from pests,” said Chan.

“New approaches are needed that allow farmers to control pests and protect pollinators simultaneously. My advice to farmers is if you find an aggregation of squash bees nesting on your farm, protect these key pollinators from exposure to neonicotinoids by either not using them at all, or at least not using them near the aggregation. Creating pesticide-free places to nest will help your population of squash bees to grow over time.”

Share Button

K+ channel study could help develop drugs for life-threatening conditions

In every living cell, from free-living bacterium to neurons in the human brain, highly specialized small conduits, known as potassium (K+) channels, are responsible for unparalleled selective and extremely rapid transport of K+-ions across the cell membrane. This unique transport mechanism of K+-ions defines the correct functional behavior of every living cell, and by extension, effectively controls a large variety of very complex processes like the normal electrical activity of brain neurons, the rhythmical beating of the human heart and the normal immune response of the human body against life threatening pathogens.

“Understanding at the atomic level, the process exploited by K+-channels to catalyze the highly selective and very rapid transport of K+-ions across the cell membrane has tantalized biophysicist for more than five decades and remains one of the most controversial areas of research,” Texas Tech University Health Sciences Center (TTUHSC) Associate Professor Luis Cuello, Ph.D., said.

Cuello and his team from TTUHSC’s Department of Cell Physiology and Molecular Biophysics recently completed a study in which they attempted to capture at atomic resolution a picture/snapshot of one of the two ion-bound configuration that seem to coexist within the selectivity filter of K+-channel. The results from the study, “Structure, function and ion binding properties of a K+-channel stabilized in the 2,4-ion bound configuration,” were published in the Aug. 5 edition of Proceedings of the National Academy of Sciences (PNAS). The publication is one of the world’s most frequently cited multidisciplinary scientific serials that disseminate cutting-edge research spanning the biological, physical and social sciences.

Cuello said two very different competing mechanistic models have tried to explain how K+-channels achieve such highly selective K+-ions transport rate. The first, a so-called canonical model championed in 2001 by Nobel laureate Roderick Mackinnon, M.D., proposes that water and K+-ions cross the cell membrane in a single file and alternate manner. Mackinnon’s model also proposes that the region of the channel that binds the K+-ions — four ions in total — can exist in two alternating ion-bound configurations: the 1,3 (i.e., K-W-K-W) and the 2,4 ion (i.e., W-K-W-K) configurations.

However, Cuello said Bert de Groot, Ph.D., put forth a model in 2014 known as the direct knock-on mechanism that challenges that of Mackinnon. The de Groot model proposes that four K+-ions within the channel selectivity filter establish direct contact within each other while crossing the cell membrane moving in single file without intervening waters.

“This topic of research has reemerged as a highly controversial one and requires further attention from a fresh and different vantage point,” Cuello explained. “Therefore, we have approached this problem by engineering a mutant channel that could isolate selectively one of the proposed ion-bound configurations, which placed us in a unique position to provide a solid answer to a long-standing question.”

Cuello said his laboratory has provided a solid experimental demonstration in favor of Mackinnon’s canonical model by engineering a mutant channel that selectively isolates the 2,4-ion bound configuration of the selectivity filter of a K+-channel. This provided the Cuello lab with a vantage point to develop a structural snapshot that demonstrates the existence of one of the two ion-bound configurations proposed by the canonical model.

Cuello hypothesized that if the four observed K+-ions bound to a K+-channel selectivity filter is the result of the coexistence of two equally occurring alternating ion-bound configurations (i.e., 1,3 and 2,4) then it should be possible to engineer a channel mutant that will bias the equilibrium between the two configurations and selectively isolate one of them.

“We have solved the crystal structure of two mutant potassium channels — KcsA-G77A and G77C — that precisely proved our hypothesis and allowed us to take a picture at atomic resolution, for the first time ever, of the 2,4-ion bound configuration of the K+-channel selectivity filter,” Cuello said. “We are proposing that our experimental results are proving that K+-ions move in a single file, with intervening water molecules, as it was originally proposed by Dr. Mackinnon in 2001.”

Cuello credited a small group of scientists from TTUHSC’s Center for Membrane Protein Research and his Department of Cell Physiology and Molecular Biophysics colleagues for working with him to complete the published research.

“Cholpon Tilegenova, a Ph.D. student in my laboratory, was the leading author in this research article since she generated the very high-resolution crystal structures of G77 mutant channels as part of her Ph.D. dissertation work,” Cuello said. “Additionally, this work would not be possible without the invaluable participation of Marien Cortes, Nermina Jahovic, Emily Hardy, Parameswaran Hariharan and my colleague, Dr. Lan Guan, who worked very hard in the functional and thermodynamic characterization of these mutant channels. Finally, I would like to knowledge Dr. Alain Labro, Dr. Luis Reuss and Dr. Guillermo Altenberg for their invaluable advice and critical thinking during the execution of this project.”

Share Button

Health24.com | There’s something in the air – as pollution gets worse, the prevalence of mental health conditions may rise

As air quality declines, the prevalence of mental health conditions may rise, a large, new study suggests.

Looking at data on millions of people in the United States and Denmark, researchers found correlations between air pollution exposure and rates of certain psychiatric disorders. In both countries, poorer air quality was linked to a slightly heightened risk of bipolar disorder.

No conclusive answers

And in Denmark – where childhood data was available – people who were exposed to polluted air in the first 10 years of life had increased risks of depression, schizophrenia and personality disorders.

The big caveat: None of that proves air pollution is to blame.

“These are only correlations,” said Dr John Ioannidis, a professor of medicine at Stanford University in California. “Inherently, data like these will never give you conclusive answers.”

Ioannidis wrote an editorial published with the study in the journal PLOS Biology.

At this point, he said, the findings are an “interesting observation” that can spur more research.

“If there really is a link, that would be very important,” Ioannidis said.

Brain inflammation

Andrey Rzhetsky, senior researcher on the study, agreed that the findings point to an association – and are not proof of cause and effect.

But animal research has offered clues about how polluted air might affect mental health, according to Rzhetsky, a professor in the departments of medicine and human genetics at the University of Chicago.

It’s been shown, for example, that fine particles in air pollution can travel to the rodent brain via the nose. And lab animals exposed to air pollutants have shown signs of brain inflammation, along with impaired learning and memory, as well as depression-like behaviour.

Ioannidis, however, cautioned against making too much of the animal research.

“You can find biology to explain whatever you want,” he said. But that doesn’t prove it’s actually happening in humans.

For the current study, Rzhetsky’s team mined data on two large populations to look for links between pollution and psychiatric conditions.

Stronger associations in Denmark

For the US portion, the investigators looked at health insurance claims for more than 151 million Americans – noting mental health diagnoses made between 2003 and 2013. They had no way to gauge people’s personal exposure to air pollution. But they did have information on air quality in each person’s county of residence – for the years 2000 to 2005.

The researchers broke those counties into seven groups (or septiles) based on air pollution. Overall, the prevalence of bipolar disorder was about 29% higher in the most-polluted group of counties, compared to the group with the cleanest air.

The Denmark data, meanwhile, showed stronger associations. There, Rzhetsky’s team had enough information to estimate childhood air-pollution exposure for nearly 1.5 million people born between 1979 and 2002.

The investigators found that people exposed to air pollution during their first 10 years of life had increased risks of developing bipolar disorder, major depression, schizophrenia or a personality disorder by age 37.

Again, the biggest difference was between the septile living in the most polluted areas, versus those breathing the cleanest air: Their rates of schizophrenia and personality disorders were more than doubled, while their rate of depression was 50% higher and bipolar disorder 29% higher.

Overall, the Danish data provided a “stronger signal”, Rzhetsky said. But does that mean that childhood exposure to air pollution during early brain development is more important than adulthood exposure?

At this point, it’s unclear, Rzhetsky said.

Many other exposures

The findings leave many unanswered questions, according to Ioannidis.

“Is it childhood exposure to air pollution that matters?” Ioannidis said. “Is it bad, no matter when you’re exposed? Or does it make no difference at all?”

That final question touches on the broader issue. Psychiatric disorders are complex, Ioannidis pointed out: They involve a mix of genetic vulnerability and a range of environmental influences.

And people living in the most polluted areas may have many other exposures that set them apart from people who breathe the cleanest air, Ioannidis said.

It’s not possible, of course, to conduct a trial where people are assigned to live in polluted areas. But, Rzhetsky said, there are other ways to approach the cause-and-effect question: For example, studies might look at whether the prevalence of mental health diagnoses goes down after air quality improves.

It will be important to figure out whether air pollution is, in fact, a contributor, Rzhetsky said, because air quality is something we can change.

Ioannidis made another point: There are already plenty of reasons to want cleaner air, since poor air quality is strongly linked to heart and lung disease, and to higher mortality.

“Air pollution is not good for us,” Ioannidis said. “We know that.”

Image credit: iStock

Share Button

Health24.com | Is MRI screening worth it for breast cancer survivors?

Breast MRI screening is a good way to detect small tumours, but it’s unclear how much it benefits women with a history of breast cancer, a new study finds.

Right now, experts recommend that breast cancer survivors have yearly mammograms to help catch any recurrences early. An unresolved question is whether adding breast MRI to that screening is beneficial.

A choice to make

In the new study, researchers found that when survivors underwent MRI screening, it did tend to detect more tumours, compared to yearly mammography alone. But it also more than doubled the number of biopsies women needed – many of which turned out to be benign.

Experts said it leaves women with a choice to make.

“Rather than deciding for women that the risks of any exam outweigh the benefits, we need to be clear and open about exactly what those risks and benefits are, and let them decide what’s most important to them,” said Dr Mary Newell, a radiologist at Emory University’s Winship Cancer Institute in Atlanta.

Newell wrote an editorial accompanying the study published online in the journal Radiology.

Breast MRIs can catch some tumours not seen on standard mammograms, but they are also more likely to spot something that turns out to be benign, according to the American Cancer Society (ACS).

Because of that, MRI is reserved for women at high risk of breast cancer. (The average US woman has about a 12% risk.) Right now, the ACS recommends MRI, along with yearly mammograms, when women have a roughly 20% or higher lifetime risk of breast cancer.

Little research evidence

That group includes women who carry certain inherited gene mutations, or who have a particularly strong family history of breast cancer.

But it does not include women with a personal history of breast cancer.

That’s because at the time the recommendations were made – in 2007 – “there simply weren’t any good studies from which we could draw conclusions,” said Robert Smith, vice-president of cancer screening for the ACS.

Even now, he said, there remains little research evidence.

The new study is the largest and most comprehensive to look at the issue so far, according to lead researcher Karen Wernli of Kaiser Permanente Washington Health Research Institute in Seattle.

Wernli and her colleagues combed through information on more than 13 000 breast cancer survivors who were screened for breast cancer at several sites across the United States. All together, they had received nearly 34 000 mammograms and about 2 500 MRI screenings between 2005 and 2012.

Overall, MRI caught more tumours – at a rate of 11 per 1 000 exams, compared to eight per 1 000 for mammography alone. To achieve that rate, though, the MRI group had to undergo more biopsies: 10% of those screenings led to a biopsy, compared to 4% of mammograms.

Potential broader impact

And while MRI detected more early tumours, it’s not clear what the ultimate benefit is: The rate of “interval” cancers – cancers diagnosed in the year between screenings – was the same in the mammography-only and MRI groups.

That suggests, according to Wernli, that mammography did about as well as MRI in detecting tumours that were “clinically important” – small tumours that would progress enough to produce symptoms (like a lump) in the next year.

Wernli pointed to the potential broader impact of using MRI screening for all women with a history of breast cancer. If every US woman diagnosed with non-advanced breast cancer in 2018 underwent one MRI, there would be more than 14 000 additional biopsies.

For individual patients, however, those types of figures may not mean much, Newell pointed out. If, she said, a woman has a lot of anxiety about a cancer recurrence, for example, she might feel the higher odds of needing a biopsy are worth it.

The decision comes down to women discussing the pros and cons of MRI screening with their doctors, the experts said.

They also agreed that more research is needed to figure out whether MRI screening benefits certain breast cancer survivors more than others.

MRI costs substantially more

Smith pointed to some examples. It might be that women with dense breast tissue – which can make mammography interpretation harder – benefit more from adding MRI. The same could be true of women with a family history of breast cancer.

But studies are needed to find out, Smith said.

There are also practical issues. Breast MRI costs substantially more than mammography, and the ACS advises women to first check that their insurance plan covers it.

Image credit: iStock

Share Button

Health24.com | The key to a long life? Apples and tea, according to experts

Apples and tea are rich in flavonoids, a group of plant compounds which provide health benefits.

While apples are rich in antioxidants, dietary fibre and vitamins, tea provides benefits such as helping with weight loss and protecting your bones. Now, experts suggest that apples and tea can prevent heart disease and cancer, particularly in heavy drinkers and smokers. 

Less cancer and heart disease

New research from Edith Cowan University (ECU) looked at the data of 53 048 Danes over the course of 23 years from the Danish Diet, Cancer and Health cohort. The study, published in Nature Communications, found that people who consumed moderate to high amounts of foods rich in flavonoids regularly were less likely to die from cancer or heart disease. Participants who consumed 500mg of flavonoids each day had the lowest risk of cancer or heart disease-related death. 

Dr Nicola Bondonno, lead researcher of the study, said that although the study found that the risk of death was lower individuals who consumed flavonoid-rich foods, the effect was stronger for those who faced a high risk of chronic diseases caused by cigarette smoking or those who drank more than two standard alcoholic beverages a day.

“These findings are important as they highlight the potential to prevent cancer and heart disease by encouraging the consumption of flavonoid-rich foods, particularly in people at high risk of these chronic diseases,” she said.

It was also noted that flavonoid consumption does not counteract all risks associated with smoking and high alcohol consumption. It is recommended that people should quit smoking and limit alcohol consumption as far as possible. “We know these kinds of lifestyle changes can be very challenging, so encouraging flavonoid consumption might be a novel way to alleviate the increased risk, while also encouraging people to quit smoking and reduce their alcohol intake.”

Flavonoids anti-inflammatory

Bondonno also recommended that people should consume a variety of flavonoid compounds, which is found in different plant based food and drinks. “This is easily achievable through the diet: one cup of tea, one apple, one orange, 100g of blueberries and 100g of broccoli would provide a wide range of flavonoid compounds and over 500mg of total flavonoids,” she said. 

While previous research has established an association between flavonoid consumption and lower risk of death, the nature of the effect was not clear and considered multifaceted. “Flavonoids have been shown to be anti-inflammatory and improve blood vessel function, which may explain why they are associated with a lower risk of death from heart disease and cancer,” according to Bondonno.

Dr Bondonno said that the next step in terms of research is to look more closely at the types of heart disease and cancers that were most inhibited by flavonoids. 

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | Vulnerable preemie babies often behind on vaccines

Preemies often lag behind full-term babies in getting routine vaccinations – and the difference remains at age three, a new study finds.

Misguided parental “hesitancy” over the safety of vaccines for preemies might be to blame, researchers said.

Findings are concerning

The study found that preterm babies were less likely to be up-to-date on seven recommended vaccines by 19 months of age. More than half were “under-vaccinated”, and by age three, one-third still were.

Experts said the findings are concerning because preemies are more likely to become seriously ill if they contract the infections that vaccines prevent.

The reasons for the results are not clear – but parents’ wariness could be a factor.

“Parents of preemies sometimes feel that they are dealing with a fragile child,” said Dr Rahul Gupta, chief medical and health officer for the March of Dimes. “Even if they’re not vaccine-hesitant as a philosophy, they may worry about the safety of vaccination for their child.”

Plus, Gupta said, there is a lot going on in those first days to weeks of life in the neonatal intensive care unit – with doctors, nurses and parents focused on various medical needs. Conversations about vaccinations may fall by the wayside.

But, Gupta stressed, it’s vital for preterm infants to get timely immunisations, since their risk of complications from infections is higher than average.

Only a couple of exceptions

“All of the available vaccines are safe and effective for preterm and low birth weight babies,” he said.

In fact, the American Academy of Pediatrics and other groups say preemies should follow the standard vaccine schedule recommended for full-term babies. Only a couple exceptions are made: The first dose of the hepatitis B vaccine, typically given in the first day of life, may be delayed; and the vaccine against rotavirus, which causes severe diarrhoea, is delayed until preemies have left the hospital.

The new findings, published in the journal Pediatrics, are based on more than 10 000 babies born in Washington state between 2008 and 2013. Just over 19% were preterm (born before the 37th week of pregnancy).

Researchers looked at whether the babies were up-to-date on the standard series of seven vaccines. It includes shots against polio, measles-mumps-rubella, diphtheria-tetanus-pertussis (whooping cough), chickenpox and hepatitis B. It also includes the “Hib” and pneumococcal vaccines, which can prevent serious bacterial infections of the lungs, blood and brain.

Overall, many babies weren’t caught up on all vaccinations by the age of 19 months – including 48% of full-term babies. But that rate was even higher among preemies, at 54%.

And by age three, the gap still hadn’t closed: Fewer than 64% of preterm toddlers were up to date, compared to 71% of their full-term peers.

Very safe and effective

The generally low rates of timely vaccination are “worrisome,” said lead researcher Dr Annika Hofstetter, of Seattle Children’s Hospital and the University of Washington. But, she added, the low numbers among preemies are especially so.

The “next big question” is to figure out what’s going on, she said.

Future studies, according to Hofstetter, could survey parents and health care providers to gauge their awareness of vaccination recommendations and the evidence on vaccine safety for preemies.

But much is already known.

“We know these vaccines are very safe and effective,” Hofstetter said. “We know preterm babies are at higher risk of complications from these infections. And now we know that they’re at risk of under-vaccination.”

The bottom line, she said, is that “we need to do a better job of getting them vaccinated in a timely manner.”

It’s understandable, Gupta said, that parents of tiny or sick newborns might be “cautious” about vaccinations. So it’s important for health care providers to address that, and for parents to ask questions, he said.

Hofstetter agreed. “If parents have any concerns, they should definitely talk to their health care provider,” she said.

Image credit: iStock

Share Button

Deducing the scale of tsunamis from the ’roundness’ of deposited gravel

Scientists from Tokyo Metropolitan University and Ritsumeikan University have found a link between the “roundness” distribution of tsunami deposits and how far tsunamis reach inland. They sampled the “roundness” of gravel from different tsunamis in Koyadori, Japan, and found a common, abrupt change in composition approximately 40% of the “inundation distance” from the shoreline, regardless of tsunami magnitude. Estimates of ancient tsunami size from geological deposits may help inform effective disaster mitigation.

Tsunamis are one of nature’s most devastating hazards; understanding their scale and mechanism is of paramount scientific and socio-economic importance. Nevertheless, despite our best efforts to study and understand them, their infrequent occurrence can make quantitative studies difficult; tsunami-causing seismic events around subduction zones (where one tectonic plate dips underneath another plate) recur once every 100 to 1,000 years, significantly reducing the number of accurately documented events. It is highly desirable that we gain some understanding by looking at geological deposits instead. However, despite some success in finding the number and age of past events, it is not yet possible to estimate the magnitude of ancient tsunamis, particularly in narrow coastal lowlands like the Sanriku Coast in Japan, struck by the 2011 Tohoku earthquake and tsunami.

Therefore, Assistant Professor Daisuke Ishimura from Tokyo Metropolitan University and Postdoctoral Fellow Keitaro Yamada from Ritsumeikan University carried out studies of gravel samples collected from bore holes and the trench in Koyadori, situated in the middle of the Sanriku coastline. Geological samples were taken corresponding to three tsunami events (AD 1611, 1896 and 2011) whose magnitudes are known, specifically their “inundation distance,” or how far they reach inland. They used automated image analysis to study how “round” each gravel particle was in their samples, giving 10 to 100 times more data than existing, manual methods. Comparing distributions with measurements of modern beach and fluvial (river) gravels, they found that they could map the number ratio between beach and fluvial gravel. They discovered that this ratio suddenly changed at a certain distance away from the sea. This point was named the “Tsunami Gravel Inflection Point” (TGIP); it is thought to arise from “run-up” (incoming) waves bringing beach material inland and “return” waves drawing inland material towards the sea. Although the TGIP occurred at different locations for each event, they found that it was always approximately 40% of the inundation distance. They applied this finding to samples corresponding to even older tsunamis, providing estimates for the size of events along the Sanriku Coast going back approximately 4,000 years for the first time.

Although the researchers believe this ratio is specific to the local topography, the same analysis may be applied to characterize other tsunami-prone locations. An accurate estimate of the extent of ancient tsunamis will expand the number of events available for future research to study the mechanisms behind tsunamis, helping to inform effective disaster mitigation and the planning of coastal communities.

Story Source:

Materials provided by Tokyo Metropolitan University. Note: Content may be edited for style and length.

Share Button

How diabetes can increase cancer risk: DNA damaged by high blood sugar

For years, scientists have been trying to solve a medical mystery: Why do people with type 1 or type 2 diabetes have an increased risk of developing some forms of cancer? Today, researchers report a possible explanation for this double whammy. They found that DNA sustains more damage and gets fixed less often when blood sugar levels are high compared to when blood sugar is at a normal, healthy level, thereby increasing one’s cancer risk.

The researchers will present their results at the American Chemical Society (ACS) Fall 2019 National Meeting & Exposition.

“It’s been known for a long time that people with diabetes have as much as a 2.5-fold increased risk for certain cancers,” says John Termini, Ph.D., who is presenting the work at the meeting. These cancers include ovarian, breast, kidney and others. “As the incidence of diabetes continues to rise, the cancer rate will likely increase, as well.”

Scientists have suspected that the elevated cancer risk for diabetics arises from hormonal dysregulation. “In people with type 2 diabetes, their insulin is not effectively carrying glucose into cells,” Termini explains. “So the pancreas makes more and more insulin, and they get what’s called hyperinsulinemia.” In addition to controlling blood glucose levels, the hormone insulin can stimulate cell growth, possibly leading to cancer. Also, most people with type 2 diabetes are overweight, and their excess fat tissue produces higher levels of adipokines than those at a healthy weight. These hormones promote chronic inflammation, which is linked to cancer. “The most common idea is that the increased cancer risk has to do with hormones,” Termini says. “That’s probably part of it, but there hasn’t been a lot of solid evidence.”

Termini, who is at City of Hope, a research and treatment center for cancer and diabetes, had a different idea. He wondered if the elevated blood glucose levels seen in diabetes could harm DNA, making the genome unstable, which could lead to cancer. So Termini and colleagues looked for a specific type of damage in the form of chemically modified DNA bases, known as adducts, in tissue culture and rodent models of diabetes. Indeed, they found a DNA adduct, called N2-(1-carboxyethyl)-2′-deoxyguanosine, or CEdG, that occurred more frequently in the diabetic models than in normal cells or mice. What’s more, high glucose levels interfered with the cells’ process for fixing it. “Exposure to high glucose levels leads to both DNA adducts and the suppression of their repair, which in combination could cause genome instability and cancer,” Termini says.

Recently, Termini and colleagues completed a clinical study that measured the levels of CEdG, as well as its counterpart in RNA (CEG), in people with type 2 diabetes. As in mice, people with diabetes had significantly higher levels of both CEdG and CEG than people without the disease.

But the team didn’t stop there. They wanted to determine the molecular reasons why the adducts weren’t being fixed properly by the cells. They identified two proteins that appear to be involved: the transcription factor HIF1α and the signaling protein mTORC1, which both show less activity in diabetes. HIF1α activates several genes involved in the repair process. “We found that if we stabilize HIF1α in a high-glucose environment, we increase DNA repair and reduce DNA damage,” Termini says. “And mTORC1 actually controls HIF1α, so if you stimulate mTORC1, you stimulate HIF1α.”

According to Termini, several drugs that stimulate HIF1α or mTORC1 already exist. The researchers plan to see if these drugs decrease cancer risk in diabetic animal models, and if so, they will test them in humans. Termini notes that metformin, a common diabetes medication that helps lower blood glucose levels, also stimulates DNA repair. “We’re looking at testing metformin in combination with drugs that specifically stabilize HIF1α or enhance mTORC1 signaling in diabetic animal models,” he says. In the meantime, a more immediate way for diabetics to reduce their cancer risk could be better control of their blood sugar. “That sounds like such an easy solution, but it’s extremely difficult for most people to maintain glycemic control,” Termini says.

Story Source:

Materials provided by American Chemical Society. Note: Content may be edited for style and length.

Share Button